Back to All Studies

Osteosarcoma is the most common bone cancer in dogs. Researchers will evaluate a specific form of immune stimulation that uses toll-like receptors. Stimulating these receptors in immune cells usually enhances anticancer immunity; however, stimulating these receptors in cancer cells could accelerate cancer progression. Thus, stimulating toll-like receptors can provide both positive (immune stimulation) and negative (osteosarcoma progression) effects. This balance has not been thoroughly evaluated in dogs with osteosarcoma, so the researchers will study the biological effects of toll-like receptors in canine osteosarcoma to determine this therapy's potential use in dogs diagnosed with osteosarcoma.

Study ID
Study Status
Start Date
Grant amount awarded
Grant recipient
University of Illinois
Study country
United States
Timothy M. Fan, DVM, PhD
Study category